Effectivity of Erythropoietin-Alpha between Fixed- and Adjusted-Dose in Chronic Kidney Disease Patients With Anemia on Hemodialysis

Autor: Mida Purwiningtyas, Bayu Dharma Santi, Budi Suprapti, Yulistiani Yulistiani

Publikováno v: Folia Medica Indonesiana; Vol 55, No 4 (2019): December; 306-310
Folia Medica Indonesiana; Vol. 55 No. 4 (2019): December; 306-310
Folia Medica Indonesiana, Vol 55, Iss 4, Pp 306-310 (2021)

Anemia is a common complication in chronic kidney disease (CKD) patient with hemodialysis. The cause of anemia is mainly due to erythropoetin deficiency because the kidneys as a erythropoetin producer are damaged. The most appropriate management of a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07098a5452dcb7e338bc27218fbca9f
https://doi.org/10.20473/fmi.v55i4.17334